连续两次单胚胎移植与双胚胎移植的有效性和安全性:英国HFEA登记研究结果
该回顾性队列研究利用英国HFEA登记数据(N=71 807),比较2010至2019年间首次取卵后行单胚胎移植(SET)、双胚胎移植(DET)或连续两次单胚胎移植(2xSET)的囊胚移植妊娠结局。2xSET的中位活产率高于SET和DET,且多胎、早产及妊娠丢失或新生儿死亡 odds 均低于DET;在39岁及以下女性中2xSET活产率持续更高,39岁以上则与DET和SET相当。
要点
- 囊胚2xSET中位活产率0.47,高于SET的0.41和DET的0.38(P<0.05)。
- 以SET为参照,2xSET多胎、早产、妊娠丢失或新生儿死亡 odds 均低于DET。
- 39岁及以下女性2xSET活产率更高,39岁以上各方案活产率相当。
核心结论
- 囊胚2xSET在39岁及以下女性中可能提供更高的活产率,在39岁以上女性中活产率与DET和SET相当,且多胎和疾病负担总体低于DET。
- 作者认为2xSET应被视为特定患者人群(包括高龄女性)的一线选择,以改善生殖结局并降低辅助生殖技术后的疾病风险。
研究设计与样本
- 回顾性队列研究,使用英国人类受精与胚胎学管理局(HFEA)登记数据,涵盖英国所有IVF诊所的全国数据。
- 纳入2010至2019年间首次取卵并接受IVF或ICSI治疗、随后行SET、DET或2xSET并使用囊胚期胚胎的所有女性(N=71 807)。
- 按母亲年龄分层,比较SET、DET和2xSET的活产率、活产婴儿率、多胎、早产及妊娠丢失或新生儿死亡率,数据分析使用RStudio v4.2,α=0.05。
主要发现
- 囊胚2xSET中位活产率0.47(四分位距[IQR]0.13),高于SET的0.41(IQR 0.13)和DET的0.38(IQR 0.13)(P<0.05)。
- 以SET为参照,2xSET多胎 odds 为OR 6.87(95%CI 6.14-7.68),DET为OR 28.20(95%CI 25.20-31.57)。
- 2xSET早产 odds 为OR 1.11(95%CI 1.06-1.15),DET为OR 2.80(95%CI 2.67-2.94)。
- 2xSET妊娠丢失或新生儿死亡 odds 为OR 1.14(95%CI 1.08-1.21),DET为OR 2.11(95%CI 1.98-2.24)。
- 39岁及以下女性中2xSET活产率持续高于DET和SET(P<0.05),39岁以上女性中结果相当(P>0.05);所有年龄组中DET多胎率最高(P<0.05)。
临床怎么用
- 作者认为2xSET应被视为特定患者人群(包括高龄女性)的一线选择,以改善生殖结局并降低辅助生殖技术后的疾病风险。
局限性
- HFEA登记数据未记录某些混杂因素,包括患者BMI、胚胎质量评估和胚胎移植时子宫内膜厚度。
- 因此,尽管分析识别了胚胎移植成功和疾病负担的总体趋势,但在特定患者人群中结果可能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: How does two-consecutive single embryo transfer (2xSET) affect reproductive outcomes of IVF and ICSI compared to double embryo transfer (DET)? SUMMARY ANSWER: Two-consecutive SET may provide greater or comparable live birth rate (LBR); with lower multiple birth, preterm birth, and pregnancy loss or neonatal death rates compared to DET. WHAT IS KNOWN ALREADY: Elective SET in IVF/ICSI is widely encouraged over DET to minimize the risk of multiple births and associated morbidities. Despite this, multiple birth rates following IVF remain higher than the 10% target across Europe and the USA. Currently, the majority of evidence regarding SET and DET is based on various studies assessing outcomes such as LBR per treatment cycle, as opposed to per oocyte retrieval. As such, the representation of SET is mostly unfavourable. Analysis of cumulative LBR following the transfer of two embryos over consecutive cycles, rather than in one transfer event (DET) is more effective at distinguishing the two methods and will therefore provide more valuable information relevant to clinical practice. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study was conducted using Human Fertilisation and Embryology Authority (HFEA) register data, which encompasses national data from all IVF clinics in the UK. All women who underwent their first oocyte retrieval and IVF or ICSI treatment cycle with subsequent SET, DET, or 2xSET between 2010 and 2019 using blastocyst embryos were included (N = 71 807). PARTICIPANTS/MATERIALS, SETTING, METHODS: The rate of live birth, liveborn baby rate, multiple birth, preterm birth, and pregnancy loss or neonatal death was compared between SET, DET, and 2xSET IVF/ICSI pregnancies using blastocyst-stage embryos, where data were stratified by maternal age. Data analysis was conducted in RStudio v4.2, alpha equals 0.05. MAIN RESULTS AND THE ROLE OF CHANCE: Blastocyst-stage 2xSET achieved a greater median LBR of 0.47 (interquartile range [IQR] 0.13) than SET, 0.41 (IQR 0.13), and DET, 0.38 (IQR 0.13) (P < 0.05). Using SET as the reference standard, 2xSET was associated with a significantly lower odds of multiple births compared to DET ((odds ratio [OR] 6.87, 95% CI 6.14-7.68) vs 28.20, 95% CI 25.20-31.57). The odds of preterm birth were also lower following 2xSET (OR 1.11, 95% CI 1.06-1.15) compared to DET (OR 2.80, 95% CI 2.67-2.94). Similarly, the odds of pregnancy loss or neonatal death were lower following 2xSET (OR 1.14, 95% CI 1.08-1.21) compared to DET (OR 2.11, 95% CI 1.98-2.24). LBR was consistently higher following 2xSET than DET and SET in women aged 39 years and under (P < 0.05). However, results were comparable in women over 39 years (P > 0.05). Across all age groups, DET pregnancies had the highest multiple birth rate (P < 0.05). In women aged 39 years and under, DET was associated with the highest preterm birth rate (P < 0.05), whereas the rate was comparable across cohorts in women over 39 (P > 0.05). Moreover, pregnancy loss and neonatal death rates were highest following DET in women aged 37 years and under (P < 0.05), and comparable to SET and 2xSET in women over 37 years (P > 0.05). LIMITATIONS, REASONS FOR CAUTION: Certain confounders are not recorded within HFEA registry data, including patient BMI, evaluation of embryo quality, and endometrial thickness at embryo transfer. Consequently, while our analysis identifies broad trends in embryo transfer success and morbidity, results may differ within certain patient populations. WIDER IMPLICATIONS OF THE FINDINGS: Blastocyst-stage 2xSET may provide greater LBR in women aged 39 years and under, and comparable LBR in women over 39 years old, with overall lower multiple birth and morbidity than DET. 2xSET should be considered first-line among certain patient cohorts, including women with advanced maternal age to improve reproductive outcomes and reduce the risk of morbidity following ART. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. None of the authors has any conflicts of interest. TRIAL REGISTRATION NUMBER: This cohort study did not require registration. Following consultation with the Institutional Review Board at Imperial College London, ethical approval was not deemed necessary.
引用
- Tighe J, Broughton S, Roberts R, et al. Effectiveness and safety of consecutive single embryo transfer compared to double embryo transfer: results from the UK HFEA registry. Hum Reprod. 2025. PMID: 39999407. doi:10.1093/humrep/deaf028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。